Nanotechnology Informs the Newest Blood Test for Cancer

    With the help of nanotechnology, scientists can now find the one cancerous cell in a blood sample. A new device, called the circulating tumor cell chip, or CTC, was developed at Massachusetts General Hospital by a team of oncologists and bioengineers and is about the size of a credit card. It separates normal blood cells from cancer cells using microscopic magnetic beads. Previously, to test for cancer, doctors needed to take a biopsy, which can be risky when tumors are in hard-to-reach organs like the lungs.

    The assay has worked on patients with known lung cancer, and now researchers are trying it, in conjunction with computed tomography (CT) scans, on people not known to have the disease. It could also help doctors quickly determine the efficacy of a given medication by being able to test a patient’s blood before and after treatment.

    It is a perilous time to be sick. Medical error kills 400,000 Americans a year, making it the third...
    Two days ago the FDA approved Addyi, a new drug meant to boost the libido in women. While some see...
    Photo by dolgachov/Thinkstock
    While we routinely make sacrifices for the people we feel closest to — our spouses, children and...
    Could our reaction to an image of an overweight or obese person affect how we perceive odor? A trio...
    illustration by Carl wiens
    Lessons learned from early organ recipients continue to hearten the future of transplant medicine....
    Molecular inhibitor represents new treatment target for drugs to halt atherosclerosis Working with...
    Gene Variation Affects Brain Cell Development Johns Hopkins researchers have begun to connect the...
    Molecular “Eat Now” Sign Makes Cells Devour Dying Neighbors A team of researchers has devised a Pac...
    Star-shaped brain cells may help control brain’s focus A new study from The Johns Hopkins...
    Discoveries hail from cataloging human proteins Striving for the protein equivalent of the Human...